About
tRNA Therapies
Areas of Focus
Categories
Gene Therapy, RNA & Peptide TherapyChina
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
3
As Collaborator
1
Total Enrollment
241
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
NOT_YET_RECRUITING: 2UNKNOWN: 2
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Today
Hover over trial bars to see details
Recent Trials
NCT06767046Lead Sponsor
KRAS-Specific Autologous TCR-T Cell Therapy for KRAS Mutation in Advanced Solid Tumors
PHASE1Not yet recruiting
18 participants
Started: Jan 10, 2025 · Completed: Dec 31, 2028
NCT06358053Lead Sponsor
CRTE7A2-01 TCR-T Cells for HPV-16 Positive Advanced Cancers
PHASE1Not yet recruiting
24 participants
Started: Apr 15, 2024 · Completed: Apr 30, 2028
NCT05122221Lead Sponsor
CRTE7A2-01 TCR-T Cell for HPV-16 Positive Advanced Cervical, Anal, or Head and Neck Cancers
PHASE1Unknown
12 participants
Started: Jul 17, 2022 · Completed: Dec 31, 2024
NCT02529579Collaborator
Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
PHASE1/PHASE2Unknown
187 participants
Started: Jun 30, 2015 · Completed: Dec 31, 2019
Locations (1)
Headquarters
Shanghai, China
Map
Loading map...